Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Levemir Flexpen
Insulin detemir 100U/mL
Solution for injection
Novo Nordisk Pharmaceuticals Limited
Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Hillerod, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Production SAS, Chartres Cedex, France
Novo Nordisk Producao Farmaceutica do Brasil Ltda, Minas Gerais, Brazil
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Levemir Innolet
Insulin detemir 100U/mL
Solution for injection
Novo Nordisk Pharmaceuticals Limited
Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Hillerod, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Production SAS, Chartres Cedex, France
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Levemir Penfill
Insulin detemir 100U/mL
Solution for injection
Novo Nordisk Pharmaceuticals Limited
Novo Nordisk A/S, Copenhagen, Denmark
Novo Nordisk A/S, Hillerod, Denmark
Novo Nordisk A/S, Kalundborg, Denmark
Novo Nordisk Production SAS, Chartres Cedex, France
Novo Nordisk Producao Farmaceutica do Brasil Ltda, Minas Gerais, Brazil
|
Dated this 31st day of October 2014.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz